A phase II study of gemcitabine and docetaxel therapy in patients with advanced urothelial carcinoma.
about
Cytotoxic and DNA-targeted therapy in urothelial cancer: have we squeezed the lemon enough?Gemcitabine and docetaxel as first-line treatment for advanced urothelial carcinoma: a phase II study.Combination of gemcitabine and carboplatin as first line treatment in elderly patients or those unfit for cisplatin-based chemotherapy with advanced transitional cell carcinoma of the urinary tract.Gemcitabine and docetaxel, an effective second-line chemotherapy for lung metastasis of urothelial carcinoma.Systemic therapy in bladder cancerPulmonary toxicity among cancer patients treated with a combination of docetaxel and gemcitabine: a meta-analysis of clinical trials.First- and second-line therapy for metastatic urothelial carcinoma of the bladderChoosing chemotherapy in patients with advanced urothelial cell cancer who are unfit to receive cisplatin-based chemotherapy.Chemotherapy in advanced bladder cancer: current status and futureConditional Survival in de novo Metastatic Urothelial CarcinomaSequential therapy with gemcitabine and Carboplatin followed by Paclitaxel as first line treatment for advanced urothelial cancer.Drug insight: Use of docetaxel in prostate and urothelial cancers.Systemic chemotherapy options for metastatic bladder cancer.Nonplatinum therapy in advanced bladder cancer.Efficacy of weekly paclitaxel treatment as a single agent chemotherapy following first-line cisplatin treatment in urothelial bladder cancer.Systemic therapy for metastatic urothelial carcinoma.Efficacy of combined gemcitabine/cisplatin chemotherapy for locally advanced or metastatic urothelial cancer.Effectiveness of capecitabine with or without docetaxel therapy for the treatment of patients with advanced urothelial carcinoma: a single-institution experienceManagement of advanced bladder cancer in patients with impaired renal function.Gemcitabine chemotherapy for the treatment of metastatic bladder carcinoma.Chemotherapeutic and targeted biological agents for metastatic bladder cancer: a comprehensive review.Docetaxel for the treatment of bladder cancer.The safety and efficacy of gemcitabine for the treatment of bladder cancer.Pazopanib synergizes with docetaxel in the treatment of bladder cancer cells.Urothelial carcinoma: the evolving landscape of immunotherapy for patients with advanced disease.
P2860
Q27026717-8229FD4B-6B68-4B0B-A50F-E11C16701422Q33364779-324F5CC9-C5FE-4F62-A2F9-832FFA6FF3CCQ33405638-D28008FA-34C3-4D86-8C27-534967EFE880Q33408261-4FDA42A8-0F2F-4954-BECD-87D258A1531FQ33578564-B74C4E0C-5170-4B3A-99D9-C0B3D6454D75Q33891037-FE2ED17E-A53C-40E4-B78C-A9D7B1D00ECFQ34541463-473BF992-9204-4799-8777-950A9663A3A0Q35076309-0EC99273-C669-4328-BDDF-E084A8567C24Q35227771-A46E5D98-6AEA-4E60-A9D0-A7FE5B79F1CFQ35756105-60451203-B9B6-4C79-ACC9-896A18913CA3Q36316576-FD169063-2745-464F-B515-E11F368886B1Q36395107-DB87DD08-D92C-426D-BF04-EF96255863F9Q36500537-7B966EB9-C226-49A1-A0FC-4339E4B0C50CQ36500541-E780BB5B-7D78-4FE7-831D-1B8D79C8EAD4Q36953789-365A98E3-E629-4F8D-B746-C0C20FFFB3AFQ37028356-EC3A8432-BD14-4D8D-B188-E9F6F1CB6DF8Q37341709-AC4ED9ED-0EE0-4256-9F48-7862D299F072Q37665453-DC4B00EA-FE8B-4D6A-A371-5DF92B88A7F0Q37894683-0BF5BE12-932C-4E7B-8FC3-B07BCA680F6BQ37896172-C39C1504-A426-45E4-8B21-27300CF4CFBFQ38181169-44EECADA-8373-45BE-9378-98A4734DA31CQ38624895-4E2CD2F8-C59C-490E-A63C-2F7BADF10B25Q38701535-D9049578-B6C3-4212-A6FB-54DB4430C4B9Q39755748-6A62A9BE-3FCB-442C-82C7-04AB59FE577DQ49192905-B09DDC2C-7AB1-4FBA-8858-F6ACE152FAD6
P2860
A phase II study of gemcitabine and docetaxel therapy in patients with advanced urothelial carcinoma.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
A phase II study of gemcitabin ...... advanced urothelial carcinoma.
@en
A phase II study of gemcitabin ...... advanced urothelial carcinoma.
@nl
type
label
A phase II study of gemcitabin ...... advanced urothelial carcinoma.
@en
A phase II study of gemcitabin ...... advanced urothelial carcinoma.
@nl
prefLabel
A phase II study of gemcitabin ...... advanced urothelial carcinoma.
@en
A phase II study of gemcitabin ...... advanced urothelial carcinoma.
@nl
P2093
P356
P1433
P1476
A phase II study of gemcitabin ...... advanced urothelial carcinoma.
@en
P2093
Barbara J Gitlitz
Carole Baker
Heather J Allen
James D Sanchez
Linda D Bosserman
Ravi Patel
Richard M Shapiro
Robert A Figlin
Yvonne Chapman
P304
P356
10.1002/CNCR.11726
P407
P577
2003-11-01T00:00:00Z